Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial Seizures
Clinical trial NCT00334958 · COMPLETED
Trial details
- NCT number
- NCT00334958
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-13
- Primary completion
- 2009-05-20
- Enrollment
- 356
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.